Section 807 of the FDA Reauthorization Act of 2017 (FDARA) requires the FDA to report on certain abbreviated new drug applications (ANDAs).
Similar Posts
FDA Responds to Evidence of Possible Association Between Autism and Acetaminophen Use During Pregnancy
The U.S. Food and Drug Administration today initiated the process for a label change for acetaminophen (Tylenol and similar products) to reflect evidence suggesting that the use of acetaminophen by pregnant women may be associated with an increased risk of neurological conditions such as autism andFDA Encourages Development of New, Reliable Alternatives to Animal Testing in Sunscreen
FDA strongly encourages companies to continue to develop new, reliable ways to minimize animal testing and to provide the data necessary for the FDA to make a GRASE determination for sunscreen active ingredients.Resources for Biomarker Requestors
Information and resources for requestors about FDA’s Biomarker Qualification ProgramWeight Loss, Male Enhancement and Other Products Sold Online or in Stores May Be Dangerous
Consumers cannot be confident that certain products, including weight loss and male enhancement products, sold on online marketplaces like Amazon and eBay or in stores, are safe to use.PDUFA VI: Fiscal Years 2018 – 2022
PDUFA VI: Fiscal Years 2018 – 2022Food Business Karison Foods & Snacks Inc Recalls ‘PANJIRI’, ‘ALSI PINNI’, ‘PUNJABI PINNI’, ‘BESAN LADDOO’, and ‘NO SUGAR ADDED BESAN LADDOO’ Due to Undeclared Milk Allergen
Karison Foods & Snacks Inc of Port Washington, NY 11050 is recalling 12 oz containers of ‘PANJIRI’, ‘ALSI PINNI’, ‘PUNJABI PINNI’, ‘BESAN LADDOO’, and ‘NO SUGAR ADDED BESAN LADDOO’ due to undeclared milk allergen